Search results
Collaboration to develop next-generation applications for PGMs
Cambridge Future Tech and Johnson Matthey launch a programme to combine scientific scouting with venture-building, to commercialise new uses of Platinum Group Metals.
Cambridge Future Tech acquires Vest Coast Capital, establishing permanent U.S. presence
Cambridge Future Tech (CFT), the deep tech venture studio, announces the acquisition of Vest Coast Capital, a U.S. based investment and advisory firm specializing in the capitalization and commercialization of transformative, early-stage technologies.
Problems with cell’s ‘plumbing’ linked to signalling issues in neurodegenerative conditions
New research led by Prof Edward Avezov (UK DRI at Cambridge) reveals how the architecture of the cell’s transport network, the endoplasmic reticulum, can go awry and lead to problems with signalling in brain cells in conditions like Alzheimer’s.
Growth Centa OS
The Marketing Centre's proprietary AI-enabled shared intelligence layer, embedded into every engagement to strengthen decisions, consistency and commercial performance.
Startup candidates want to understand their impact, not just their package
A strong startup offer does not start at the offer stage. It starts with a clear interview process.
Equity still matters in startups.
CMO's CMO
Experienced strategic support and challenge for senior marketing leaders navigating growth, transformation or complexity.
Fractional CAIO
Senior, board-level leadership to help businesses apply AI strategically, responsibly and commercially — not just experiment with tools.
Activation Team
Flexible marketing execution capacity that turns agreed strategy into consistent, measurable delivery.
Growth Foundations
A structured eight-week programme that gives businesses clarity and direction before scaling marketing activity.
Automating hiring before fixing interviews is the wrong order
The risk is not that AI replaces human judgement. The risk is that teams automate around weak judgement instead of improving it.
HR teams are under pressure to do more with less.
Candidates need clearer interviews too
A strong interview answer is not just a story. It is evidence of judgement, action and impact.
Candidates are facing a harder hiring market.
Lolly: achieved 25% YoY growth with strategic marketing support
It's Lolly, a hospitality technology innovator, needed sharper focus to scale — fractional Marketing Director Mark Pearson (Eastern Counties) helped narrow its target markets, clarify messaging, and align strategy with the company's vision, delivering consistent 25%+ year-on-year growth.
AI will not fix hiring teams that still run weak interviews
AI can make hiring faster. It cannot make a weak interview process fair, structured or evidence-led by default.
AI is already changing how internal recruitment teams work.
Sona Insurance: Creating a Strategic System for Sustainable Growth
Sona Insurance, an independent broker, had grown through word-of-mouth alone — no CRM, no marketing history, no in-house infrastructure. Fractional CMO Stephen Rumbelow built a complete demand generation system from scratch, delivering a 265% increase in organic and direct website visits in four months.
How to interview when the role will change before the person starts
In a startup, you are not only hiring for the role in front of you. You are hiring for the role it may become.
Startup roles rarely stay still.
Award-winning cybersecurity: how FullProxy increased revenue by 135%
FullProxy, a Glasgow-based cybersecurity consultancy serving healthcare, financial services and critical infrastructure clients, had strong technical expertise but no strategic marketing capability. A Fractional CMO rebuilt its positioning from "reseller" to "trusted advisor," delivering 135% revenue growth year-on-year.
Growth in 2026: What Really Works (and What's Holding SMEs Back)
SME growth isn't being held back by lack of effort — most leadership teams are already busy. The real blocker is fragmentation: misaligned priorities, patchy data and disconnected marketing activity.
Brand building in 2026: a practical guide for SME leaders
Brand is often treated as a design exercise. This guide argues it's a commercial one — the clearer and more consistent a business is about who it helps and how it delivers, the faster it sells, prices with confidence, and grows.
How to build an AI roadmap for SMEs: a practical guide for 2026
Most SMEs don't fail at AI because the tools are wrong — they fail because they never built a plan. This guide sets out a practical, staged approach to AI adoption, starting with data foundations and ending with scaled, governed use across the business.
Stop hiring heroes but build a repeatable interview system instead.
A scaling company cannot rely on heroic judgement. It needs repeatable evidence.
Every founder wants people who can raise the level of the company.
Rainmaker – ILM Level 5
The Rainmaker – ILM Level 5 programme is an accredited leadership development programme designed for experienced managers who want to enhance their strategic leadership capability and drive organisational improvement.
The programme supports leaders to:
Gonville Hotel Welcomes Exciting New Era with Radisson Individuals Celebration
Gonville Hotel was delighted to celebrate an exciting milestone as we officially joined Radisson Individuals, marking the beginning of an exciting new chapter for the hotel.
Launch of new AI Academy to help businesses unlock growth
Cambridgeshire Chamber of Commerce launches new AI Academy to help businesses unlock growth through artificial intelligence
Crossing the Blood-Brain Barrier: Why Natural Transport Mechanisms Are the Smarter Route
Most biologics and even small molecules fail to cross the blood-brain barrier, leaving CNS drug delivery a persistent bottleneck. Isogenica's latest short video looks at why researchers are turning to the brain's own transport systems as a more promising path in.
Solving LNP's Liver Problem: Why Targeting Is the Next Frontier in RNA Delivery
Lipid nanoparticles have powered the RNA medicine revolution, but their default tendency to accumulate in the liver limits use beyond hepatic disease.